Interdonor variability of platelet response to thrombin receptor activation: Influence of Pl(A2) polymorphism

British Journal of Haematology

Volumn 99, Issue 4, 1997, Pages 801-807

  Lasne, Dominique ^a,b   Krenn, Maria ^a,d   Pingault, Véronique ^a   Arnaud, Emmanuel ^a,b   Fiessinger, Jean Noël ^b,c   Aiach, Martine ^a,b   Rendu, Francine ^b  

^a HÔPITAL BROUSSAIS   (France)

^b INSERM   (France)

^c BICHAT HOSPITAL   (France)

^d Inst Pharmaceutical Technol/B   (Austria)

Author keywords

GPIIIa; Pl(A2) polymorphism; Platelet; Thrombin receptor; TRAP

Indexed keywords

ADENOSINE DIPHOSPHATE; AMASTATIN; DNA; GLYCOPROTEIN IIIA; SYNTHETIC PEPTIDE; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; ALLELE; ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOSIS;

EID: 0031456787     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4973300.x     Document Type: Article

References (37)

1. 3 for angiogenesis. Science, 264, 569-571.
2. Cannon, C.P., McCabe, C.H., Henry, T.D., Schweiger, M.J., Gibson, R.S., Mueller, H.S., Becker, R.C., Kleiman, N.S., Haugland, J.M., Anderson, J.M., Anderson, J.L., Sharaf, B.L., Edwards, S.J., Rogers, W.J., Williams, D.O. & Braunwald, E. (1944) A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 5 trial. Journal of the American College of Cardiologists, 23, 993-1003.
3. A polymorphism in young men with myocardial infarction. Lancet, 348, 485-486.
4. Cartwright, I.J., Hampton, K.K., Macneil, S., Colvin, B.T. & Preston, F.E. (1994) A haemorrhagic platelet disorder associated with altered stimulus-response coupling and abnormal membrane phospholipid composition. British Journal of Haematalogy, 88, 129-136.
5. Chao, B.H., Kalkunte, S., Maraganore, J.M. & Stone, S.R. (1992) Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry, 31, 6175-6178.
6. Coller, B.S., Peerschke, E.L., Scudder, L.E. & Sullivan, C.A. (1983) A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoprotein IIb/IIIa complex. Journal of Clinical Investigation. 72, 325-330.
7. Coller, B.S., Ward, P., Ceruso, M., Scudder, L.E., Springer, K., Kutok, J.L. & Prestwich, G.D. (1992) Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence. nuclear magnetic resonance spectroscopy. and cleavage by amonipeptidase M. Biochemistry, 31, 11713-11720.
8. Coughlin, S.R. (1994) Expanding horizons for receptors coupled to G proteins: diversity and disease. Current Opinion in Cell Biology, 6, 191-197.
9. Dawson, S.J., Wiman, B., Hamsten, A., Green, F., Humphries, S. & Henney, A.M. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in hepG2 cells. Journal of Biological Chemistry, 268, 10739-10745.
10. Felding-Habermann, B. & Cheresh, D.A. (1993) Vitronectin and its receptors. Current Opinion in Cell Science, 5, 864-868.
11. 3) function via the thrombin receptor. Biochemical Journal, 309, 613-620.
12. Greco, J.N. & Jamieson, G.A. (1991) High and moderate affinity pathways for α-thrombin-induced platelet activation. Proceedings of the Society for Experimental Biology and Medicine, 198, 792-799.
13. Green, F., Kelleher, C., Wilkes, H., Temple, A., Meade, T. & Humphries, S. (1991) A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arteriosclerosis and Thrombosis, 11, 540-546.
14. Hanson, S.R. & Harker, L.A. (1988) Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenyl-alanyl-L-prolyl-L-arginyl chloromethyl ketone. Proceedings of the National Academy of Sciences of the United States of America, 85, 3184-3188.
15. Heras, M., Chesebro, J.H., Penny, W.J., Bailey, K.R., Badimon, L. & Fuster, V. (1989) Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Circulation, 79, 657-665.
16. Holmsen, H., Day, H.D. & Storm, E. (1969) Adenine nucleotide metabolism of blood platelets: subcellular localization of nucleotide pools with different functions in the platelet release reaction. Biochimica et Biophysica Acta, 186, 254-266.
17. Humphries, S.E., Green, F.R., Thomas, A.E., Kelleher, C.H. & Meade, T.W. (1991) Genetic control of plasma fibrinogen levels: an example of gene-environment interaction in the etiology of a multifactorial disorder. Etiology of Human Disease at the DNA Level (ed. by J. Lindsten and U. Petterson), pp. 115-128. Raven Press, New York.
18. 455-A B-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Arteriosclerosis and Thrombosis in Vascular Biology, 15, 96-104.
19. Ishihara, H., Connolly, A.J., Zeng, D., Kahn, M.L., Zheng, Y.W., Timmons, C., Tram, T. & Coughlin, S.R. (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-507.
20. Jang, I.K., Gold, H.K., Zisking, A.A., Leinbach, R.C., Fallon, J.T. & Collen, D. (1990) Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation, 81, 219-225.
21. Jin, Y., Dietz, H.C., Nurden, A. & Bray, P.F. (1993) Single strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphism in the gene for glycoprotein IIIa. Blood, 82, 2281-2288.
22. A polymorphism and myocardial infarction. New England Journal of Medicine, 335, 1071-1072.
23. Miller, S.A., Dyks, D.D. & Polesky, H.F. (1988) A simple procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
24. 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochemical Journal, 304, 537-542.
25. Newman, P.J. (1991) Platelet GPIIb-IIIa: molecular variation and alloantigens. Thrombosis and Haemostasis, 66, 111-118.
26. Nysledt, S., Emilsson, K., Wahlestedt, C. & Sundelin, J. (1994) Molecular cloning of a potential novel proteinase activated receptor. Proceedings of the National Academy of Sciences of the United States of America, 91, 9208-9212.
27. O' Brien, E.R., Garvin, M.R., Stweart, D.K., Hinohara, T., Simpson, J.B., Schwartz, S.M. & Giachelli, C.M. (1994) Osteopontin is synthetized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arteriosclerosis and Thrombosis, 14, 1648-1656.
28. Osborn, S.V., Hampton, K.K., Smillie, D., Channer, K.S. & Daly, M.E. (1996) Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet, 348, 1309-1310.
29. 2+ mobilization. FEBS Letters, 288, 123-128.
30. Rendu, F., Maclouf, J., Launay, J.M., Boinot, C., Levy-Toledano, S., Tanzer, J. & Caen, J. (1987) Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylations. American Journal of Hematology, 25, 165-174.
31. Serruys, P.W., Herrman, J.P.R., Simon, J.P.R., Rutsch, W., Bode, C., Laarman, G.J., Van Dijk, R., Van den Bos, A.A, Umans, V.A.W.M., Fox, K.A.A., Close, P. & Deckers, J.W. (1995) A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. New England Journal of Medicine, 333, 757-763.
32. Shattil, S.J. (1995) Function and regulation of the β3 integrins in hemostasis and vascular biology. Thrombosis and Haemostasis, 74, 149-155.
33. Tiruppathi, C., Lum, H., Andersen, T., Fenton, J.W., II & Malik, A.B. (1992) Thrombin receptor 14-amino acid peptide binds to endothelial cells and stimulates calcium transients. American Journal of Physiology, 263, L595-L601.
34. Topol, E.J., Fuster, V., Harrington, R.A., Califf, R.M., Kleiman, N.S., Kereiakes, D.J., Cohen, M., Chapekis, A., Gold, H.K., Tannenbaum, M.A., Rao, A.K., Debowey, D., Schwarz, D., Henis, M. & Chesebro, J. (1994) Recombinant hirudin for unstable angina pectoris: a multicenter. randomized angiographie trial. Circulation, 89, 1557-1566.
35. Vassallo, R.R., Kieber-Emmons, T., Cichowski, K. & Brass, L.F. (1992) Structure-function relationships in the activation of platelet thrombin receptors by receptor-derivated peptides. Journal of Biological Chemistry, 267, 6081-6085.
36. Vu, T.K.H., Hung, D.T., Wheaton, V.I. & Coughlin, S.R. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057-1068.
37. Weiss, E.J., Bray, P.F., Tayback, M., Schulman, S.P., Kickler, T.S., Becker, L.C., Weiss, J.L., Gerstenblith, G. & Goldschmidt-Clermont, P.J. (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New England Journal of Medicine, 334, 1090-1094.